Pharming Group (PHGUF) Projected to Post Quarterly Earnings on Thursday

Pharming Group (OTCMKTS:PHGUF) will likely be issuing its quarterly earnings data on Thursday, March 13th. Analysts expect the company to announce earnings of $0.01 per share and revenue of $76.67 million for the quarter.

Pharming Group Stock Performance

Shares of OTCMKTS:PHGUF opened at $0.90 on Thursday. The stock has a market capitalization of $606.85 million, a P/E ratio of -45.22 and a beta of 1.00. Pharming Group has a 1-year low of $0.75 and a 1-year high of $1.20. The company has a current ratio of 3.53, a quick ratio of 2.76 and a debt-to-equity ratio of 0.53. The business has a 50-day moving average price of $0.92 and a two-hundred day moving average price of $0.84.

Pharming Group Company Profile

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.